Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cardiogenic shock: therapy and prevention

W L Barry1, I J Sarembock

  • 1Department of Internal Medicine, University of Virginia Health Sciences Center, Charlottesville 22908, USA.

Clinical Cardiology
|March 10, 1998
PubMed
Summary

Cardiogenic shock, a severe circulatory failure, affects 7.5% of acute myocardial infarction patients. Prompt revascularization, like primary angioplasty, and risk-factor identification are crucial for effective treatment and prevention.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

LPP expression during in vitro smooth muscle differentiation and stent-induced vascular injury.

Circulation research·2006
Same author

Should glycoprotein IIb/IIIa inhibitors be used during all percutaneous coronary interventions? No.

Journal of thrombosis and haemostasis : JTH·2004
Same author

The role of inflammation in vascular injury and repair.

Journal of thrombosis and haemostasis : JTH·2003
Same author

Adenosine A(2A) receptor stimulation reduces inflammation and neointimal growth in a murine carotid ligation model.

Arteriosclerosis, thrombosis, and vascular biology·2001
Same author

Selective alpha(v)beta(3)-receptor blockade reduces macrophage infiltration and restenosis after balloon angioplasty in the atherosclerotic rabbit.

Circulation·2001
Same author

Dexamethasone inhibits macrophage accumulation after balloon arterial injury in cholesterol fed rabbits.

Atherosclerosis·2001

Area of Science:

  • Cardiology
  • Critical Care Medicine

Background:

  • Cardiogenic shock is a critical complication of acute myocardial infarction (AMI).
  • It signifies profound circulatory failure, leading to inadequate tissue perfusion.
  • Affects approximately 7.5% of AMI patients, indicating significant clinical relevance.

Observation:

  • Treatment involves inotropic agents, intra-aortic balloon counterpulsation, and revascularization strategies.
  • Primary angioplasty is supported by current evidence for AMI-related cardiogenic shock.
  • Surgical intervention is indicated for patients with triple-vessel disease.

Findings:

  • Thrombolytic therapy is an alternative if early catheterization is unavailable.
  • Transfer to an interventional facility is recommended for eligible patients.
  • Effective management necessitates a comprehensive prevention strategy.

Implications:

  • Early identification of high-risk patients is essential for shock prevention.
  • Aggressive intervention selection improves patient outcomes.
  • Multifaceted treatment approaches are vital for managing cardiogenic shock.

Related Experiment Videos